National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

ifosfamide
A synthetic analogue of the nitrogen mustard cyclophosphamide with antineoplastic activity. Ifosfamide alkylates and forms DNA crosslinks, thereby preventing DNA strand separation and DNA replication. This agent is a prodrug that must be activated through hydroxylation by hepatic microsomal enzymes. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Ifomide
Iphosphamid
iphosphamide
Isoendoxan
Iso-Endoxan
isophosphamide
Naxamide
US brand names:Cyfos
Ifex
Ifosfamidum
Foreign brand names:Holoxan
Holoxane
IFO-Cell
Ifolem
Ifomida
Ifoxan
Mitoxana
Tronoxal
Abbreviations:IFF
IFO
IFX
IPP
Code names:Asta Z-4942
MJF-9325
Z-4942
Chemical structure names:
  • 2-oxo-N,3-bis-(2-chloroethyl) tetrahydro-2H-1,3,2-oxazaphosphorin- 2-amine
  • 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin-2-oxide
  • N,3-bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide



Previous:Idamycin, idarubicin, idiotype-pulsed autologous dendritic cell vaccine APC8020, idoxuridine, Ifex
Next:Ifosfamidum, IGF-1R antagonist BMS-754807, IGF-1R inhibitor OSI-906, IH636 grape seed proanthocyanidin extract, IL-2 plasmid DNA/lipid complex

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov